Literature DB >> 19652943

Intracardiac metastasis of a Malignant Mixed Mullerian tumor (MMMT): progressive dyspnoea due to obstruction of the left atrium and the left ventricle without left ventricular dysfunction or primary lung disease.

Ludger J Ulbricht1, Matthias Kunert, Bernhard Gremmler, Nikolaos Evagelopoulos, Arno Krian, Jürgen Moege.   

Abstract

Malignant Mixed Mullerian tumors (MMMT) are rare gynecological tumors. Even with surgical treatment, chemotherapy, and/or radiotherapy, outcome is poor. MMMTs are known to metastasize to the liver, the abdomen, and the lungs. One case of an ocular metastasis has been reported. In a 61-year-old female patient who had undergone surgical resection of a Mullerian tumor of the uterus 26 months prior to being admitted to our department, we found an obstructing left atrial mass. Histopathologic assessment of this lesion after surgical resection revealed a Mullerian tumor metastasis. Immediately after surgery, the patient was asymptomatic, but was readmitted 4 months later with dyspnoea. Echocardiography and CT revealed new masses in the left atrium and left ventricle. On a literature review, we did not find any description of left atrial and left ventricular occluding metastases of MMMT.

Entities:  

Mesh:

Year:  2009        PMID: 19652943     DOI: 10.1007/s10354-009-0698-0

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  13 in total

1.  Metastatic mixed mullerian tumour of the esophagus.

Authors:  J Papadimitriou; B Smyrniotis; J Condis; S Antoniou
Journal:  Int Surg       Date:  1989 Jul-Sep

2.  Axillary metastasis from a malignant mullerian mixed tumor.

Authors:  Marco Antonio Cura; Mario Blanco; Lisa Esserman
Journal:  Breast J       Date:  2002 Sep-Oct       Impact factor: 2.431

Review 3.  Extragenital malignant mixed müllerian tumor: review of the literature.

Authors:  J R Garde; M A Jones; R McAfee; H M Tarraza
Journal:  Gynecol Oncol       Date:  1991-11       Impact factor: 5.482

4.  Malignant mixed müllerian tumors of the uterus. A clinicopathologic assessment of 34 cases.

Authors:  K W Barwick; V A LiVolsi
Journal:  Am J Surg Pathol       Date:  1979-04       Impact factor: 6.394

5.  Patterns of recurrence in malignant mixed müllerian tumor of the uterus.

Authors:  W J Spanos; L J Peters; M J Oswald
Journal:  Cancer       Date:  1986-01-01       Impact factor: 6.860

6.  Central nervous system involvement secondary to metastatic mixed müllerian tumor of the uterus.

Authors:  G Cormio; A Colamaria; G Di Vagno; E Pierangeli; G Vailati; L Selvaggi
Journal:  Gynecol Obstet Invest       Date:  1997       Impact factor: 2.031

7.  Primary peritoneal carcinosarcoma (malignant mixed mullerian tumor): Report of a case with five-year disease free survival after surgery and chemoradiation and a review of literature.

Authors:  Ma-Lee Ko; Cherng-Jye Jeng; Shih-Hung Huang; Jenta Shen; Chii-Ruey Tzeng; Su-Chee Chen
Journal:  Acta Oncol       Date:  2005       Impact factor: 4.089

Review 8.  Primary malignant mixed Müllerian tumor of the vagina.

Authors:  D Neesham; P Kerdemelidis; J Scurry
Journal:  Gynecol Oncol       Date:  1998-08       Impact factor: 5.482

9.  Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.

Authors:  Michael Callister; Lois M Ramondetta; Anuja Jhingran; Thomas W Burke; Patricia J Eifel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-03-01       Impact factor: 7.038

Review 10.  Extragenital malignant mixed müllerian tumor.

Authors:  K T Chen; R W Wolk
Journal:  Gynecol Oncol       Date:  1988-07       Impact factor: 5.482

View more
  1 in total

1.  Uterine carcinosarcomas (malignant mixed müllerian tumours): a review with special emphasis on the controversies in management.

Authors:  Rani Kanthan; Jenna-Lynn Senger
Journal:  Obstet Gynecol Int       Date:  2011-10-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.